-
Je něco špatně v tomto záznamu ?
Circadian variation in hematological toxicity of the immunosuppressive agent "Mycophenolate Mofetil" in rats
Ichrak Dridi, Wafa Ben-Cherif, Karim Aouam, Mohsen Hassine, Mossadok Ben-Attia, Alain Reinberg, Naceur Abderrazak Boughattas
Jazyk angličtina Země Česko
Typ dokumentu práce podpořená grantem
NLK
Free Medical Journals
od 2003 do 2013
Freely Accessible Science Journals
od 2003 do 2013
ROAD: Directory of Open Access Scholarly Resources
od 2002
- MeSH
- anemie chemicky indukované krev MeSH
- cirkadiánní rytmus * fyziologie MeSH
- IMP-dehydrogenasa antagonisté a inhibitory aplikace a dávkování toxicita MeSH
- imunosupresiva aplikace a dávkování toxicita MeSH
- inhibitory enzymů MeSH
- krysa rodu rattus MeSH
- kyselina mykofenolová * analogy a deriváty aplikace a dávkování toxicita MeSH
- léková chronoterapie * MeSH
- leukopenie chemicky indukované krev MeSH
- nežádoucí účinky léčiv MeSH
- počet erytrocytů statistika a číselné údaje MeSH
- počet leukocytů statistika a číselné údaje MeSH
- potkani Wistar MeSH
- rozvrh dávkování léků MeSH
- studie případů a kontrol MeSH
- tělesná teplota fyziologie MeSH
- trombocytopenie chemicky indukované krev MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Because of biological rhythms, drug efficiency and toxicity vary according to the time of administration of the drug. This study investigates whether the haematological toxicity of the immunosuppressive agent Mycophenolate Mofetil varies according to the circadian dosing-time in rats. 300 mg/kg of Mycophenolate Mofetil was injected by i.p. route to different groups of animals at six different circadian stages (1, 7, 13, and 19 Hours After Light Onset, HALO). Mycophenolate Mofetil treatment induced a significant decrease at 7 HALO in red blood cells (-18%), in haemoglobin rate (-15%) and in white blood cells (-54%). These parameters followed a circadian rhythm with an acrophase located at the end of the light-rest phase. A significant thrombocytopenia was observed according to MMF the circadian dosing-time. In the controls, the number of platelets followed a circadian rhythm. Mycophenolate Mofetil modified this rhythm which became an 8-h ultradian rhythm. The data indicate that, the Mycophenolate Mofetil-induced haematological toxicity was maximum when the drug was administered in the middle of the light-rest phase, which is physiologically analogous to the end of the activity of the diurnal phase in human patients.
Laboratory of Hematology CHU Fattouma Bourguiba Monastir Tunisia
Laboratory of Pharmacology Faculty of Medecine University of Monastir Tunisia
Unit of Chronobiology Foundation A de Rothschild Paris France
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13028216
- 003
- CZ-PrNML
- 005
- 20131022083809.0
- 007
- ta
- 008
- 130902s2013 xr d f 000 0eng||
- 009
- AR
- 024 7_
- $a 10.2478/v10136-012-0024-9 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Dridi, Ichrak $u Laboratory of Pharmacology, Faculty of Medecine, University of Monastir, Tunisia
- 245 10
- $a Circadian variation in hematological toxicity of the immunosuppressive agent "Mycophenolate Mofetil" in rats / $c Ichrak Dridi, Wafa Ben-Cherif, Karim Aouam, Mohsen Hassine, Mossadok Ben-Attia, Alain Reinberg, Naceur Abderrazak Boughattas
- 504 __
- $a Literatura
- 520 9_
- $a Because of biological rhythms, drug efficiency and toxicity vary according to the time of administration of the drug. This study investigates whether the haematological toxicity of the immunosuppressive agent Mycophenolate Mofetil varies according to the circadian dosing-time in rats. 300 mg/kg of Mycophenolate Mofetil was injected by i.p. route to different groups of animals at six different circadian stages (1, 7, 13, and 19 Hours After Light Onset, HALO). Mycophenolate Mofetil treatment induced a significant decrease at 7 HALO in red blood cells (-18%), in haemoglobin rate (-15%) and in white blood cells (-54%). These parameters followed a circadian rhythm with an acrophase located at the end of the light-rest phase. A significant thrombocytopenia was observed according to MMF the circadian dosing-time. In the controls, the number of platelets followed a circadian rhythm. Mycophenolate Mofetil modified this rhythm which became an 8-h ultradian rhythm. The data indicate that, the Mycophenolate Mofetil-induced haematological toxicity was maximum when the drug was administered in the middle of the light-rest phase, which is physiologically analogous to the end of the activity of the diurnal phase in human patients.
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a cirkadiánní rytmus $x fyziologie $7 D002940
- 650 _2
- $a imunosupresiva $x aplikace a dávkování $x toxicita $7 D007166
- 650 12
- $a kyselina mykofenolová $x analogy a deriváty $x aplikace a dávkování $x toxicita $7 D009173
- 650 _2
- $a inhibitory enzymů $7 D004791
- 650 _2
- $a IMP-dehydrogenasa $x antagonisté a inhibitory $x aplikace a dávkování $x toxicita $7 D007168
- 650 _2
- $a nežádoucí účinky léčiv $7 D064420
- 650 _2
- $a rozvrh dávkování léků $7 D004334
- 650 _2
- $a trombocytopenie $x chemicky indukované $x krev $7 D013921
- 650 _2
- $a leukopenie $x chemicky indukované $x krev $7 D007970
- 650 _2
- $a anemie $x chemicky indukované $x krev $7 D000740
- 650 _2
- $a počet erytrocytů $x statistika a číselné údaje $7 D004906
- 650 _2
- $a počet leukocytů $x statistika a číselné údaje $7 D007958
- 650 _2
- $a tělesná teplota $x fyziologie $7 D001831
- 650 12
- $a léková chronoterapie $7 D055870
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ben-Cherif, Wafa $u Laboratory of Pharmacology, Faculty of Medecine, University of Monastir, Tunisia
- 700 1_
- $a Aouam, Karim $u Laboratory of Pharmacology, Faculty of Medecine, University of Monastir, Tunisia $7 gn_A_00007685
- 700 1_
- $a Hassine, Mohsen $u Laboratory of Hematology, CHU Fattouma Bourguiba, Monastir, Tunisia
- 700 1_
- $a Mossadok, Ben-Attia $u Laboratory of Biomonitoring of the Environment (LR01/ES14), Faculty of Science of Bizerta, University of Carthage, Bizerta, Tunisia
- 700 1_
- $a Reinberg, Alain $u Unit of Chronobiology, Foundation A. de Rothschild Paris, France
- 700 1_
- $a Boughattas, Naceur $u Laboratory of Pharmacology, Faculty of Medecine, University of Monastir, Tunisia
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 11, č. 2 (2013), s. 71-78 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2013/02/03.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 3 $z 0
- 990 __
- $a 20130902075546 $b ABA008
- 991 __
- $a 20131022084359 $b ABA008
- 999 __
- $a ok $b bmc $g 992240 $s 826648
- BAS __
- $a 3
- BMC __
- $a 2013 $b 11 $c 2 $i 1214-021X $m Journal of Applied Biomedicine $n J. Appl. Biomed. (Čes. Budějovice Print) $x MED00012667 $d 71-78
- LZP __
- $c NLK188 $d 20131022 $a NLK 2013-37/ip